帕金森病的治疗。
The treatment of Parkinson's disease.
作者信息
Godwin-Austen R B
出版信息
Postgrad Med J. 1977 Dec;53(626):729-31. doi: 10.1136/pgmj.53.626.729.
Abstract
The treatment of Parkinson's disease is discussed. Levodopa is the most effective drug in this therapy. The place of other agents is discussed.
摘要
本文讨论了帕金森病的治疗方法。左旋多巴是该治疗中最有效的药物。文中还讨论了其他药物的作用。
相似文献
1
The treatment of Parkinson's disease.帕金森病的治疗。
Postgrad Med J. 1977 Dec;53(626):729-31. doi: 10.1136/pgmj.53.626.729.
2
[Treatment of Parkinson disease].[帕金森病的治疗]
Arq Neuropsiquiatr. 1995 Mar;53(1):1-10. doi: 10.1590/s0004-282x1995000100001.
3
Ropinirole as compared with levodopa in Parkinson's disease.罗匹尼罗与左旋多巴治疗帕金森病的比较。
N Engl J Med. 2000 Sep 21;343(12):884; author reply 885. doi: 10.1056/NEJM200009213431211.
4
Levodopa in the treatment of Parkinson's disease: current controversies.左旋多巴治疗帕金森病：当前的争议
Mov Disord. 2005 May;20(5):643; author reply 643-4. doi: 10.1002/mds.20435.
5
Current controversies: levodopa in the treatment of Parkinson's disease.当前争议：左旋多巴在帕金森病治疗中的应用
Mov Disord. 2005 May;20(5):642-3; author reply 643-4. doi: 10.1002/mds.20444.
6
Parkinson's disease.帕金森病
Compr Ther. 1986 Mar;12(3):25-9.
7
Recent developments in the treatment of Parkinson's disease.
Geriatrics. 1985 Feb;40(2):34-8, 41.
8
Sudden appearance of invalidating dyskinesia-dystonia and off fluctuations after the introduction of levodopa in two dopaminomimetic drug naive patients with stage IV Parkinson's disease.在两名未经多巴胺模拟药物治疗的IV期帕金森病患者中，左旋多巴引入后突然出现无效性运动障碍-肌张力障碍和症状波动。
J Neurol Neurosurg Psychiatry. 1998 Oct;65(4):605-6. doi: 10.1136/jnnp.65.4.605.
9
A hospital-based study: risk factors in development of motor complications in 555 Parkinson's patients on levodopa therapy.一项基于医院的研究：555例接受左旋多巴治疗的帕金森病患者发生运动并发症的危险因素。
Clin Neurol Neurosurg. 2006 Dec;108(8):726-32. doi: 10.1016/j.clineuro.2006.02.002. Epub 2006 Mar 27.
10
Extended-release amantadine (Gocovri) for dyskinesia in Parkinson's disease.缓释金刚烷胺（Gocovri）用于治疗帕金森病的运动障碍。
Med Lett Drugs Ther. 2017 Dec 4;59(1535):198-200.
本文引用的文献
1
Effect of age and arteriosclerosis on the response of Parkinsonian patients to levodopa.年龄和动脉硬化对帕金森病患者左旋多巴反应的影响。
Br Med J. 1971 Nov 27;4(5786):522-4. doi: 10.1136/bmj.4.5786.522.
2
L-dopa in Parkinsonism and the influence of previous thalamotomy.帕金森病中的左旋多巴及既往丘脑切开术的影响。
Br Med J. 1971 Jan 2;1(5739):7-13. doi: 10.1136/bmj.1.5739.7.
Zotero 插件